The Latest Cardiac and Vascular News
BRISBANE, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK) today announced that the first patient has been dosed in the company’s Phase 2 clinical trial of danicamtiv (formerly MYK-491) in people with primary dilated cardiomyopathy (DCM) thought to be caused by genetic mutations of the sarcomere. Danicamtiv […]
Early successes in roll-out of world’s most complete solution for atrial fibrillation VANCOUVER, British Columbia–(BUSINESS WIRE)–Kardium Inc. announced the first commercial procedures with the Globe Mapping and Ablation System. The Globe System is the most complete solution for the treatment of atrial fibrillation (AF) – the world’s most common heart rhythm disorder, […]
SEATTLE, Sept. 8, 2020 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading developer and provider of remote ambulatory cardiac monitoring and digital health solutions, announced today the appointment of Kevin Hykes as President and Chief Executive Officer, effective August 31, 2020. Hykes will also become a member of BardyDx’s Board of Directors. With over 28 years of experience in the […]
Company to accelerate development of advanced approaches for management of heart failure CAMPBELL, Calif., Sept. 8, 2020 /PRNewswire/ — Adona Medical, a Shifamed portfolio company, announced today the closing of a $22M Series A financing, which will be used to advance product development, support pre-clinical testing, and expand the team as the company furthers its […]
IDE Approval to Pave the Way for Pivotal Study of CGuard System for Carotid Artery Disease and Stroke Prevention in the United States TEL AVIV, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke […]
TEL AVIV, Israel, Sept. 8, 2020 /PRNewswire/ — MedHub Ltd, a medical technology company specializing in the development and commercialization of AI powered technologies that aid in the diagnosis of cardiac disease, announced today the appointment of Prof. Rafael Beyar as the Chairman of the company’s Board of Directors. As MedHub continues to execute on its go-to-market […]
Grant Will Support Continued Development of CoreMap’s Technology to Enable Curative, Patient-Specific Treatment of Atrial Fibrillation BURLINGTON, Vt., Sept. 08, 2020 (GLOBE NEWSWIRE) — CoreMap, Inc. announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF) to support development of […]
Company selected from over 500 applicants in first-of-its-kind Digital Health Technologies Pilot SAN FRANCISCO and LONDON, Sept. 08, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, has today been named a winner of the Artificial Intelligence (AI) in Health and Care Award. […]
Breakthrough Technology, Combined with Acutus Non-Contact Mapping May Enable Rapid, Safe and Effective Arrhythmia Treatment CARLSBAD, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (NASDAQ:AFIB) today announced pre-clinical experimental results of a novel diagnostic and therapeutic workflow utilizing the AcQMap® System along with tissue-selective, non-thermal pulse field ablation (PFA) via […]
PASADENA, Calif.–(BUSINESS WIRE)–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the board of directors appointed veteran pharmaceutical industry executive Oye Olukotun, M.D., MPH, as an independent director of the company, with a term beginning effective September 1, 2020. Douglass Given, M.D., Ph.D., Chairman of the Board of Arrowhead, said, “Oye […]
